123 related articles for article (PubMed ID: 35788353)
1. MRI and FUNDUS image fusion for improved ocular biometry in Ocular Proton Therapy.
Via R; Pica A; Antonioli L; Paganelli C; Fattori G; Spaccapaniccia C; Lomax A; Weber DC; Schalenbourg A; Baroni G; Hrbacek J
Radiother Oncol; 2022 Sep; 174():16-22. PubMed ID: 35788353
[TBL] [Abstract][Full Text] [Related]
2. Potential and pitfalls of 1.5T MRI imaging for target volume definition in ocular proton therapy.
Via R; Hennings F; Pica A; Fattori G; Beer J; Peroni M; Baroni G; Lomax A; Weber DC; Hrbacek J
Radiother Oncol; 2021 Jan; 154():53-59. PubMed ID: 32890606
[TBL] [Abstract][Full Text] [Related]
3. 3D MRI-based tumor delineation of ocular melanoma and its comparison with conventional techniques.
Daftari Ik; Aghaian E; O'Brien JM; Dillon W; Phillips TL
Med Phys; 2005 Nov; 32(11):3355-62. PubMed ID: 16372413
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Magnetic Resonance Imaging-Based and Conventional Measurements for Proton Beam Therapy of Uveal Melanoma.
Jaarsma-Coes MG; Ferreira TA; Marinkovic M; Vu THK; van Vught L; van Haren GR; Rodrigues MF; Klaver YLB; Verbist BM; Luyten GPM; Rasch CRN; Beenakker JM
Ophthalmol Retina; 2023 Feb; 7(2):178-188. PubMed ID: 35840053
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of ultra-high-field MRI for three-dimensional visualisation of tumour size in uveal melanoma patients, with direct relevance to treatment planning.
Beenakker JW; Ferreira TA; Soemarwoto KP; Genders SW; Teeuwisse WM; Webb AG; Luyten GP
MAGMA; 2016 Jun; 29(3):571-7. PubMed ID: 26915081
[TBL] [Abstract][Full Text] [Related]
6. Use of high-frequency ultrasound imaging to improve delineation of anterior uveal melanoma for proton irradiation.
Daftari I; Barash D; Lin S; O'Brien J
Phys Med Biol; 2001 Feb; 46(2):579-90. PubMed ID: 11229735
[TBL] [Abstract][Full Text] [Related]
7. Fundus image fusion in EYEPLAN software: an evaluation of a novel technique for ocular melanoma radiation treatment planning.
Daftari IK; Mishra KK; O'Brien JM; Tsai T; Park SS; Sheen M; Phillips TL
Med Phys; 2010 Oct; 37(10):5199-207. PubMed ID: 21089753
[TBL] [Abstract][Full Text] [Related]
8. Proton therapy of uveal melanomas: intercomparison of MRI-based and conventional treatment planning.
Marnitz S; Cordini D; Bendl R; Lemke AJ; Heufelder J; Simiantonakis I; Kluge H; Bechrakis NE; Foerster MH; Hinkelbein W
Strahlenther Onkol; 2006 Jul; 182(7):395-9. PubMed ID: 16826358
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional MRI-based treatment planning approach for non-invasive ocular proton therapy.
Fleury E; Trnková P; Erdal E; Hassan M; Stoel B; Jaarma-Coes M; Luyten G; Herault J; Webb A; Beenakker JW; Pignol JP; Hoogeman M
Med Phys; 2021 Mar; 48(3):1315-1326. PubMed ID: 33336379
[TBL] [Abstract][Full Text] [Related]
10. Response to "Letter to the Editor of Radiotherapy and Oncology regarding the paper titled "MRI and FUNDUS image fusion for improved ocular biometry in Ocular Proton Therapy" by Via et al.".
Via R; Fattori G; Pica A; Paganelli C; Lomax A; Schalenbourg A; Weber DC; Baroni G; Hrbacek J
Radiother Oncol; 2022 Nov; 176():252. PubMed ID: 35988774
[No Abstract] [Full Text] [Related]
11. Letter to the Editor of Radiotherapy and Oncology regarding the paper titled "MRI and FUNDUS image fusion for improved ocular biometry in Ocular Proton Therapy" by Via et al.
Beenakker JM; Rasch CRN
Radiother Oncol; 2022 Nov; 176():251. PubMed ID: 35988772
[No Abstract] [Full Text] [Related]
12. The Economic Value of MR-Imaging for Uveal Melanoma.
Grech Fonk L; Ferreira TA; Webb AG; Luyten GPM; Beenakker JM
Clin Ophthalmol; 2020; 14():1135-1143. PubMed ID: 32425499
[TBL] [Abstract][Full Text] [Related]
13. Three-Dimensional Eye Shape, Myopic Maculopathy, and Visual Acuity: The Zhongshan Ophthalmic Center-Brien Holden Vision Institute High Myopia Cohort Study.
Guo X; Xiao O; Chen Y; Wu H; Chen L; Morgan IG; He M
Ophthalmology; 2017 May; 124(5):679-687. PubMed ID: 28237427
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance safety and compatibility of tantalum markers used in proton beam therapy for intraocular tumors: A 7.0 Tesla study.
Oberacker E; Paul K; Huelnhagen T; Oezerdem C; Winter L; Pohlmann A; Boehmert L; Stachs O; Heufelder J; Weber A; Rehak M; Seibel I; Niendorf T
Magn Reson Med; 2017 Oct; 78(4):1533-1546. PubMed ID: 27851881
[TBL] [Abstract][Full Text] [Related]
15. [Three-dimension reconstruction of ocular fundus image].
Chen J; Peng C
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Feb; 25(1):177-81. PubMed ID: 18435285
[TBL] [Abstract][Full Text] [Related]
16. Practice Patterns Analysis of Ocular Proton Therapy Centers: The International OPTIC Survey.
Hrbacek J; Mishra KK; Kacperek A; Dendale R; Nauraye C; Auger M; Herault J; Daftari IK; Trofimov AV; Shih HA; Chen YE; Denker A; Heufelder J; Horwacik T; Swakoń J; Hoehr C; Duzenli C; Pica A; Goudjil F; Mazal A; Thariat J; Weber DC
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):336-343. PubMed ID: 27084651
[TBL] [Abstract][Full Text] [Related]
17. Uveal melanoma: quantitative evaluation of diffusion-weighted MR imaging in the response assessment after proton-beam therapy, long-term follow-up.
Foti PV; Longo A; Reibaldi M; Russo A; Privitera G; Spatola C; Raffaele L; Salamone V; Farina R; Palmucci S; Musumeci A; Caltabiano R; Ragusa M; Mariotti C; Avitabile T; Milone P; Ettorre GC
Radiol Med; 2017 Feb; 122(2):131-139. PubMed ID: 27752969
[TBL] [Abstract][Full Text] [Related]
18. Personalized Anatomic Eye Model From T1-Weighted Volume Interpolated Gradient Echo Magnetic Resonance Imaging of Patients With Uveal Melanoma.
Nguyen HG; Sznitman R; Maeder P; Schalenbourg A; Peroni M; Hrbacek J; Weber DC; Pica A; Bach Cuadra M
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):813-820. PubMed ID: 29970318
[TBL] [Abstract][Full Text] [Related]
19. Multi-channel MRI segmentation of eye structures and tumors using patient-specific features.
Ciller C; De Zanet S; Kamnitsas K; Maeder P; Glocker B; Munier FL; Rueckert D; Thiran JP; Bach Cuadra M; Sznitman R
PLoS One; 2017; 12(3):e0173900. PubMed ID: 28350816
[TBL] [Abstract][Full Text] [Related]
20. Multi-modality imaging of uveal melanomas using combined PET/CT, high-resolution PET and MR imaging.
Beyer T; Pietrzyk U; Knoess C; Vollmar S; Wienhard K; Kracht L; Bockisch A; Maderwald S; Kühl H; Fitzek M
Nuklearmedizin; 2008; 47(2):73-9. PubMed ID: 18392316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
